4 free views remaining today

Gaucher's disease type II

ICD-10 Codes

Related ICD-10:

Description

Gaucher's Disease Type II: A Rare and Severe Form

Gaucher's disease type II, also known as acute neuropathic Gaucher's disease, is a rare and severe form of Gaucher's disease. It is characterized by early-onset and severe neurological involvement of the brainstem, associated with an organomegaly and generally leading to death before the age of 2 [3].

Key Features:

  • Poor development: Infants with Gaucher's disease type II often experience poor development, including delayed motor skills and cognitive impairment [2].
  • Seizures: Seizures are a common feature of this condition, indicating severe neurological involvement [1].
  • Spasticity (jerking movements): Spasticity or jerking movements can also occur in individuals with Gaucher's disease type II [2].
  • Poor ability to suck and swallow: Infants may experience difficulty sucking and swallowing due to the accumulation of glucocerebroside in the spleen and liver [1].
  • Enlarged liver and spleen (hepatosplenomegaly): Enlargement of both the liver and spleen is a hallmark feature of Gaucher's disease type II, leading to organomegaly [4].

Causes and Genetics

Gaucher's disease type II is caused by mutations in the gene encoding acid β-glucosidase (GBA), which leads to a deficiency of this enzyme. This deficiency results in the accumulation of glucocerebroside in various organs, including the spleen, liver, and brain [5].

Prognosis

Unfortunately, Gaucher's disease type II is generally fatal before the age of 2 due to severe neurological involvement and organomegaly [3]. Early diagnosis and treatment are crucial for managing symptoms and improving quality of life.

References: [1] Context result 2 [2] Context result 2 [3] Context result 3 [4] Context result 6 [5] Context result 5

Additional Characteristics

  • Seizures
  • Enlarged liver and spleen (hepatosplenomegaly)
  • Poor development
  • Spasticity (jerking movements)
  • Poor ability to suck and swallow

Signs and Symptoms

Diagnostic Tests

Gaucher's disease type II is a rare and severe form of the disorder that affects infants younger than 6 months old. The diagnostic tests for this condition are crucial in confirming the diagnosis and providing an early start to treatment.

Blood Test: Enzyme Activity Testing A blood test can detect Gaucher's disease by checking for enzyme levels, specifically β-glucosidase enzyme activity [8]. This test measures the amount of enzyme present in the blood, which is typically low or absent in individuals with Gaucher's disease.

DNA Test: Genotype Testing Genetic testing can also confirm a diagnosis of Gaucher's disease by identifying mutations in the GBA1 gene that cause the disease [5]. This test can determine if an individual has two copies of the affected Gaucher gene, indicating they have the disease, or one copy, which means they are a carrier.

Other Diagnostic Tests In addition to enzyme activity testing and genetic testing, other diagnostic tests may be performed to confirm a diagnosis of Gaucher's disease type II. These include:

  • A bone marrow biopsy or smear can detect Gaucher cells, but it is not recommended as a diagnostic tool [6].
  • Liver function enzyme testing and associated marker testing may also be conducted to rule out other conditions [9].

Early Detection through Newborn Screening Gaucher's disease type II may be detected through newborn screening tests performed soon after birth [13]. This early detection allows for prompt initiation of treatment, which can improve outcomes.

It is essential to consult with a healthcare professional or a specialist in Gaucher's disease to determine the best course of action and diagnostic testing for an individual suspected of having this condition.

Treatment

Current Treatment Options for Gaucher Disease Type 2

Unfortunately, there is no effective treatment available for Gaucher disease type 2, which is the most severe and progressive form of the disease [7]. Babies with this condition usually pass away within two to three years [7].

However, it's essential to note that enzyme replacement therapy (ERT), which is used to treat patients with Type 1 and 3 Gaucher disease, is not effective in treating the severe brain involvement associated with Gaucher disease types 2 and 3 [5]. Currently, there are no specific treatments available for Gaucher disease type 2.

No Effective Treatment Options

  • No specific treatment for Type 2 Gaucher disease is available [9].
  • Enzyme replacement therapy, which is used to treat patients with Type 1 and 3 Gaucher disease, is not effective in treating the severe brain involvement associated with Gaucher disease types 2 and 3 [5].

Symptom Management

While there may be no cure for Gaucher disease type 2, treatment can help manage symptoms. Children who inherit the disease usually don’t live past age 2, but treatment can help manage symptoms [11].

Recommended Medications

  • No effective treatment available
  • Enzyme replacement therapy not effective
  • Symptom management only

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Additional Differential Diagnoses

  • Item 1
  • Item 2
  • Item 3

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5293
owl#annotatedSource
t374888
22-rdf-syntax-ns#first
t4027725
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
ORDO:77260
oboInOwl#id
DOID:0110958
core#notation
DOID:0110958
IAO_0000115
A Gaucher's disease characterized by rapid neurologic deterioration with cranial nerve and extrapyramidal tract involvement that has_material_basis_in homozygous or compound heterozygous mutation in the GBA1 gene on chromosome 1q22.
oboInOwl#hasExactSynonym
Infantile Cerebral Gaucher Disease
rdf-schema#label
Gaucher's disease type II
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
rdf-schema#subClassOf
t375161
RO_0004019
http://purl.obolibrary.org/obo/SO_0001537
relatedICD
http://example.org/icd10/E75.2
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.